STOCK TITAN

Selectquote Inc SEC Filings

SLQT NYSE

Welcome to our dedicated page for Selectquote SEC filings (Ticker: SLQT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

SelectQuote, Inc. filings document formal disclosures for a public insurance distribution and healthcare services company. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentation exhibits, and segment information for Senior, Healthcare Services, Life, and SelectRx-related activity.

The company’s regulatory filings also cover capital-structure matters, including a senior secured credit facility and revolving credit facility, as well as NYSE continued-listing compliance disclosures. Governance records include annual meeting voting results for director elections, auditor ratification, and advisory executive-compensation matters, while amended event reports document corrections to previously furnished earnings materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 shows President Robert Clay Grant’s latest equity activity at SelectQuote (SLQT) on 1–2 Aug 2025. Seven tranches of previously granted RSUs and price-vested units vested (transaction code M), delivering ≈631,089 common shares at $0 exercise cost. A day later, 204,163 shares were withheld at $1.74 to cover taxes (code F). Direct ownership after the transactions rose to 2,891,334 shares.

Grant continues to hold significant indirect stakes—1.24 M shares in a personal trust, 184.2 k shares across three children’s trusts, and 1.09 M shares via Haakon Capital—plus unvested derivative holdings. Table II records new equity compensation awards: 460 k time-based RSUs and 460 k price-vested RSUs granted on 1 Aug 2025 (code A), each convertible 1-for-1 into common stock and subject to multi-year vesting/performance hurdles. Remaining unvested derivative balance totals several hundred-thousand units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Morgan Stanley has filed a passive Schedule 13G disclosing beneficial ownership of SelectQuote, Inc. (SLQT) common stock as of 30 June 2025.

  • Shares owned: 10,134,048
  • Ownership percentage: 5.6 % of shares outstanding
  • Voting/Dispositive power: 0 sole; 10.13 M shared
  • Reporting person type: HC, CO (parent holding company/control person)

The filing states the position was acquired and is held in the ordinary course of business with no intent to influence control. Signature was provided by Authorized Signatory Christopher O’Hara on 5 Aug 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
current report

FAQ

How many Selectquote (SLQT) SEC filings are available on StockTitan?

StockTitan tracks 38 SEC filings for Selectquote (SLQT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Selectquote (SLQT)?

The most recent SEC filing for Selectquote (SLQT) was filed on August 6, 2025.